Literature DB >> 21314885

Recreational ketamine: from pleasure to pain.

Dan Wood1, Angela Cottrell, Simon C Baker, Jennifer Southgate, Maya Harris, Simon Fulford, Christopher Woodhouse, David Gillatt.   

Abstract

Ketamine has become increasingly recognized as a drug of recreational use. Individuals using significant amounts have developed symptoms including a small painful bladder, ureteric obstruction, papillary necrosis and hepatic dysfunction. The present paper examines the current literature on the relationship between ketamine use and these symptoms. Our own clinical experience and the data available clarify the causal relationship, and further data help to elucidate the mechanism of damage. On the basis of continued work and development with patients who are ketamine users we suggest an assessment and treatment regime that includes cessation of ketamine use and adequate analgesia to overcome symptoms. In conclusion, it is important for medical practitioners who encounter patients with these symptoms to ask about recreational drug use. Ketamine remains a safe and effective drug to use under appropriate medical supervision. Patients identified as suffering from this syndrome will need to be referred to a urological unit with an interest in the treatment of the condition.
© 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21314885     DOI: 10.1111/j.1464-410X.2010.10031.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  24 in total

1.  Acute and chronic toxicity pattern in ketamine abusers in Hong Kong.

Authors:  Chan Yiu-Cheung
Journal:  J Med Toxicol       Date:  2012-09

Review 2.  Ketamine: The final frontier or another depressing end?

Authors:  Omar K Sial; Eric M Parise; Lyonna F Parise; Tamara Gnecco; Carlos A Bolaños-Guzmán
Journal:  Behav Brain Res       Date:  2020-02-01       Impact factor: 3.332

3.  Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine.

Authors:  David M Wood; Susannah Davies; Malgorzata Puchnarewicz; Atholl Johnston; Paul I Dargan
Journal:  Eur J Clin Pharmacol       Date:  2011-12-29       Impact factor: 2.953

4.  Demonstration of the direct impact of ketamine on urothelium using a tissue engineered bladder model.

Authors:  Michel Bureau; Jérôme Pelletier; Alexandre Rousseau; Geneviève Bernard; Stéphane Chabaud; Stéphane Bolduc
Journal:  Can Urol Assoc J       Date:  2015-09-09       Impact factor: 1.862

5.  Repeated ketamine exposure induces an enduring resilient phenotype in adolescent and adult rats.

Authors:  Eric M Parise; Lyonna F Alcantara; Brandon L Warren; Katherine N Wright; Roey Hadad; Omar K Sial; Kyle G Kroeck; Sergio D Iñiguez; Carlos A Bolaños-Guzmán
Journal:  Biol Psychiatry       Date:  2013-06-19       Impact factor: 13.382

Review 6.  [Ketamine in the therapy of chronic pain and depression].

Authors:  Wolfgang Jaksch; Rudolf Likar; Martin Aigner
Journal:  Wien Med Wochenschr       Date:  2019-04-12

7.  Ketamine-Induced Cystitis: A Comprehensive Review of the Urologic Effects of This Psychoactive Drug.

Authors:  Danyon J Anderson; Jessica Zhou; David Cao; Matthew McDonald; Maya Guenther; Jamal Hasoon; Omar Viswanath; Alan D Kaye; Ivan Urits
Journal:  Health Psychol Res       Date:  2022-09-15

8.  Ketamine bladder syndrome: an important differential diagnosis when assessing a patient with persistent lower urinary tract symptoms.

Authors:  Shalom Srirangam; Joe Mercer
Journal:  BMJ Case Rep       Date:  2012-09-30

9.  Long-term ketamine abuse induces cystitis in rats by impairing the bladder epithelial barrier.

Authors:  Di Gu; Jun Huang; Youle Yin; Zhengfei Shan; Shaobin Zheng; Peng Wu
Journal:  Mol Biol Rep       Date:  2014-08-05       Impact factor: 2.316

10.  Ketamine/Xylazine-Induced Corneal Damage in Mice.

Authors:  Demelza Koehn; Kacie J Meyer; Nasreen A Syed; Michael G Anderson
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.